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Abstract
A case of a 26-year-old man without continuity of blood flow in the level of the isthmus of the
aorta is described. During interventional catheterization, we reconstructed this continuity and
implanted a vascular stent. (Cardiol J 2008; 15: 80–84)
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Introduction
Coarctation of the aorta (CoA) is a common
congenital cardiovascular defect [1]. It is usually
diagnosed in children but occasionally in adults. The
latter patients are usually asymptomatic, and the
diagnosis of CoA is made during an attempt to iden-
tify the cause of high blood pressure. Untreated CoA
most commonly leads to death by the fifth decade
of life [2, 3]. Early symptoms include intermittent
claudication, headaches, vomiting, nausea and diz-
ziness. Less common clinical manifestations have
also been reported, including congestive heart fail-
ure, infectious endocarditis involving aortic intima,
true ascending or descending aortic aneurysm, aor-
tic dissection and cerebrovascular events [3, 4].
Surgical treatment of CoA was described for the
first time in 1945, with a number of methods of sur-
gical repair of the aorta introduced since that time.
In 1979 a postmortem study showed the feasibility
of balloon angioplasty of lesions, and the first per-
cutaneous balloon angioplasty of CoA in an infant
with heart failure was performed in 1982. Soon this
procedure was also introduced in adult patients. Due
to suboptimal results caused by vessel hypoplasia,
elastic recoil or restenosis, modifications of balloon
angioplasty were sought to solve these problems. In
1993 the first stent implantation into the aortic isth-
mus was performed in clinical practice by Suares de
Lezo (followed by the publication of these results in
1995) [2, 5, 6], and since that time this method has
become widely used in all age groups [4, 7–10].
In this report, we present a patient with criti-
cal CoA, also known as functionally [11] or physio-
logically interrupted aortic arch, with coexisting
atrial septal defect who was treated with percuta-
neous stent implantation into the aortic isthmus.
Case report
A 26-year-old man, a foreigner, was presented
to our centre for percutaneous treatment of CoA.
The defect was diagnosed in childhood, but the par-
ents of the patient did not consent to the suggest-
ed surgical treatment. The patient grew and devel-
oped normally during childhood, but he required
treatment for his hypertension. For six years blood
pressure was well controlled using two antihyper-
tensive drugs. In addition, intermittent claudication
developed, leading to progressively more severe
symptoms.
On admission, the patient was in a good general
clinical condition. No pulses within the lower limbs
were noted during the physical examination, and
heart auscultation revealed fixed splitting of the
second heart sound and late systolic murmur in the
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left interscapular area and in the 2nd–3rd left inter-
costal space. Blood pressure on the upper limbs was
155/95 mm Hg. Chest radiography showed normal
cardiac silhouette, abnormal contour of the aorta and
rib notching. Echocardiography revealed morpho-
logically severe stenosis of the aortic isthmus with
a pressure gradient that was difficult to measure,
and slow flow in the abdominal aorta. Cardiac cham-
ber dimensions were normal for body mass, and the
thickness of left ventricular myocardium was in-
creased by 22%. In addition, bileaflet aortic valve
and an atrial septal defect with a diameter of 12 mm
and a left-to-right shunt were found. The patient
was scheduled for an attempt at percutaneous dila-
tation of CoA. Simultaneous closure of the atrial
septal defect was also contemplated but the patient
did not agree to the latter due to financial reasons.
Cardiac catheterization was performed following
intravenous sedation using midazolam and morphine,
under antibiotic coverage (cephazolin), by percutane-
ous femoral artery approach using 6 F sheath. A mul-
tipurpose catheter was introduced into the descend-
ing aorta, and multiple attempts to cross the coarcta-
tion were made using various guidewires (Teflon,
hydrophilic and coronary), but the catheter only en-
tered numerous wide collateral vessels (Fig. 1).
The multipurpose catheter was replaced with a 6 F
pigtail catheter used for aortography below the aor-
tic isthmus but no uncontrasted blood flow to the
descending arm of the aortic arch was seen (Fig. 2).
The aortic diameter at the level of the diaphragm
was 21 mm. Interruption of the aortic arch was then
suspected and a 6 F multipurpose catheter was in-
troduced through the right femoral vein (via a 6 F
sheath) to the left atrium, left ventricle and the as-
cending aorta. Using a 260 cm-long 0.035-inch
guidewire, the multipurpose catheter was replaced
with a pigtail catheter used for aortography of the
ascending aorta. Again, no flow through the entire
length of the aorta could be seen (Fig. 3), and the
descending aorta was visualized after a delay nec-
essary for the inflow of contrasted blood through
collateral vessels. Anatomic continuity of aortic
walls was found, with the vessel lumen not seen
(atresia? septating membrane?) at a length of only
1 mm (14 mm below the origin of the left subclavi-
an artery) and a clearly visible cone of blind-ended
proximal aorta. During multiple attempts to cross
the presumed CoA, a 0.035-inch hydrophilic Teru-
mo guidewire entered the descending aorta (perfo-
ration of an aortic septating membrane? crossing
narrow minimal CoA lumen that was not seen in
Figure 1. Collateral vessels.
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aortography?). Using this guidewire, a multipurpose
catheter was introduced into the descending aorta
and the guidewire was replaced with a 260 cm-long
0.035-inch Teflon guidewire, with the tip of the
latter left in the abdominal aorta. The pressure
gradient between the ascending and descending
aorta was estimated at 61 mm Hg. Subsequently,
a Microvena snare catheter advanced through the
femoral artery sheath was used to catch and exte-
riorize the guidewire tip. Using this arteriovenous
loop, and after replacing the femoral artery sheath
with a long 12 F Mullins sheath, a 16 mm × 4 cm
Maxi balloon with mounted P 4014 stent (Johnson
& Johnson) was introduced into CoA. The stent was
expanded just below the origin of the left subclavi-
an artery, resulting in dilatation of the stenosed
aortic segment to 16 mm (Fig. 4). Following the
procedure, the pressure gradient decreased to zero.
Follow-up aortography showed a minimal aneurysm
and incomplete apposition of the stent to the aortic
walls above and below the site of previous steno-
sis. A follow-up catheterization with a view to re-
peated stent dilatation was scheduled for six months
later. The patient presented for the follow-up eval-
uation 18 months later. During that time he had no
symptoms, and antihypertensive drugs were initially
Figure 2. Aortography below the isthmus does not
reveal ‘negative’ contrast.
Figure 4. Aortography after stent implantation.
Figure 3. Aortography reveals stopped blood flow in
the isthmus of the aorta.
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used in reduced doses and later completely with-
drawn. Blood pressure was 120/80 to 135/85 mm Hg.
Physical examination showed normal pulses in
the lower limbs, and echocardiography revealed
normal flow in the abdominal aorta with a mini-
mal diastolic plateau. Pressure gradient at the
aortic isthmus was estimated at 20 mm Hg. The
atrial septal defect size decreased from 12 to
7 mm. The patient did not give consent for stent
dilatation.
Discussion
Coarctation of the aorta may be treated surgi-
cally or percutaneously. The choice of the therapeu-
tic option should be based on patient preference.
This patient presented to our centre for percuta-
neous treatment.
Diagnostic evaluation revealed an extreme
form of CoA that occurs very rarely in this age group
and is the functional equivalent of an interrupted
aortic arch. Nevertheless, we decided to rise to the
challenge and attempt percutaneous restoration of
the aortic lumen [12] using a transvenous approach
to the ascending aorta (through the atrial septal
defect).
Having the choice between balloon angioplasty
and percutaneous stent implantation, we decided to
perform the latter. Conventional indications for
stenting include unfavourable anatomy for balloon
angioplasty, such as tubular coarctation, hypoplasia
of the isthmus, long stenosed aortic segment [2, 8]
and the lack of the effect of balloon angioplasty or
restenosis following angioplasty. However, stents
are now used more commonly and in some centres
they have become a first line treatment in all adult
patients, and in some centres stents are used as
a palliative treatment even in small children [5]. Lit-
erature review suggests that the advantages of
stents compared to balloon angioplasty include sig-
nificantly lower residual pressure gradient and
lower rates of restenosis and direct aortic wall dam-
age [5, 10]. According to Suarez de Lezo et al. [5],
even a long time after balloon angioplasty there is
a 10 to 15 percent risk of the development of an an-
eurysm. Data are inconsistent in regard to the rate
of aneurysm development following both types of
percutaneous treatment: some authors suggest that
this occurs at a similar rate following both stenting
and balloon angioplasty, estimated at 6–7%, but oth-
er investigators reported more frequent aneurysm
development following balloon angioplasty [5, 6, 13].
Aneurysms develop due to damage of the aortic me-
dia, and overestimation of the diameter of the bal-
loon used for angioplasty is suggested as a contrib-
uting cause [6]. In some cases, stents may protect
against such complications, so the rate of aneurysm
development might be lower following stenting [13].
Appropriate sizing of the balloon is very important.
The balloon diameter should be 1–2 mm smaller
than the diameter of the aortic isthmus (most com-
monly at the level of the origin of the left subclavi-
an artery), and it should not be larger that the di-
ameter of the aorta at the level of the diaphragm
[6, 14]. If an aneurysm develops, it might be occlud-
ed percutaneously using coils or a covered stent
[7, 9, 15]. Stent implantation may also result in other
complications including stent fracture or migration,
thromboembolic events or aortic rupture [7, 8]. The
risk of the latter may by reduced by the use of an
appropriately sized balloon, but on the other hand,
the use of a smaller balloon to expand the stent may
be responsible for incomplete apposition of the stent
to the aortic wall below the treated segment [10],
as was the case in our patient. However, if the ste-
nosis is very severe, a two-stage approach is advo-
cated, with repeated procedure at approximately six
months. During this time, a scar forms in the area
of previous angioplasty, and then stent redilatation
is performed using balloons to shape appropriately
the stent as dictated by the vessel morphology.
Another decision is the choice between balloon pre-
dilatation and primary stenting. Most of the availa-
ble data from the literature suggest that primary
stenting reduces the risk of aortic wall damage and
this approach is used in most centres [2, 7, 8]. In
our experience, balloon predilatation is helpful in
cases of restenosis following surgical treatment as
this approach allows assessment of the aortic wall
susceptibility to expansion, an important issue with
hard, incompliant lesions. With this information, we
can avoid implanting a stent that could not be suc-
cessfully dilated later.
Our patient had critically narrow CoA. Due to
the risk of aortic rupture, we considered implanta-
tion of a covered stent. However, this is associated
with a risk of obstructing blood flow to intercostal
arteries supplying the spinal cord [9, 16, 17], so we
decided to implant a regular uncovered stent, hav-
ing a covered stent at our disposal in case of any
adverse effects of stenting. During subsequent fol-
low-up, the patient’s blood pressure lowered, al-
though dilatation of the stenosed aortic isthmus,
either surgical or percutaneous, does not always
lead to blood pressure normalization due to persisting
receptor dysregulation [6]. In fact, this effect is less
often seen in patients above 4–6 years of age. Availa-
ble data suggest that blood pressure normalization
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following dilatation of CoA occurs in 50–79% of
patients [6].
Unfortunately, even successful lowering of the
pressure gradient does not fully protect the patient
from increased cardiovascular morbidity during
adult life, although this risk is significantly lower.
Potential sequelae include hypertension, aneurysm
development, premature coronary artery disease, in-
flammation of the intima and formation of a fistula [4].
As a result, such patients require subsequent peri-
odic cardiovascular evaluation.
Percutaneous intervention performed in our
patient resulted in a significant reduction of the
shunt through the abnormal communication at the
level of the interatrial septum, driven by reduced
left ventricular pressures, and possibly also reduced
left atrial pressures (due to increased diastolic ven-
tricular compliance). As the diameter of the atrial
septal defect decreased by 40%, it did not require
closure any longer.
Conclusions
Percutaneous treatment of CoA is feasible even
in patients with functionally interrupted aortic arch-
es or extremely severe forms of CoA. For such pro-
cedures to be performed, all necessary equipment
including covered stents must be available in the
cardiac catheterization laboratory. In addition, imme-
diate access to cardiac surgery is required in case
surgical treatment should become necessary.
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